agent: be added to aspirin

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents biological agent
Weight: 0.76
, real estate agent
Weight: 0.65
, source
Weight: 0.64
, contractor
Weight: 0.62
Siblings travel agent
Weight: 0.75
, representative
Weight: 0.67
, beta blocker
Weight: 0.65
, solicitor
Weight: 0.63
, attorney
Weight: 0.62

Related properties

Property Similarity
be added to aspirin 1.00
be effective as antianginal medications 0.79
be effective as medications 0.78
be added to medicines 0.76
be contraindicated in patients with asthma 0.76
be used in angina 0.76
be contraindicated in angina 0.76
be contraindicated in vasospastic angina 0.76
be used in hypertension 0.75
be contraindicated with allergy shots 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.10
Rule weight: 0.13
Evidence weight: 0.94
Similarity weight: 0.79
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin) ⋁
Evidence: 0.83
¬ Remarkable(beta blocker, be effective as antianginal medications)
0.10
Rule weight: 0.13
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin) ⋁
Evidence: 0.67
¬ Remarkable(beta blocker, be contraindicated in patients with asthma)
0.10
Rule weight: 0.13
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin) ⋁
Evidence: 0.64
¬ Remarkable(beta blocker, be contraindicated in vasospastic angina)
0.09
Rule weight: 0.13
Evidence weight: 0.94
Similarity weight: 0.76
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin) ⋁
Evidence: 0.85
¬ Remarkable(beta blocker, be used in angina)
0.09
Rule weight: 0.13
Evidence weight: 0.94
Similarity weight: 0.75
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin) ⋁
Evidence: 0.87
¬ Remarkable(beta blocker, be used in hypertension)

Remarkability from sibling implausibility

0.44
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.79
Evidence: 0.10
Plausible(agent, be added to aspirin) ⋁
Evidence: 0.83
Remarkable(beta blocker, be effective as antianginal medications) ⋁
Evidence: 0.57
¬ Plausible(beta blocker, be effective as antianginal medications)
0.43
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.76
Evidence: 0.10
Plausible(agent, be added to aspirin) ⋁
Evidence: 0.85
Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.46
¬ Plausible(beta blocker, be used in angina)
0.43
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.75
Evidence: 0.10
Plausible(agent, be added to aspirin) ⋁
Evidence: 0.87
Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.49
¬ Plausible(beta blocker, be used in hypertension)
0.35
Rule weight: 0.60
Evidence weight: 0.77
Similarity weight: 0.76
Evidence: 0.10
Plausible(agent, be added to aspirin) ⋁
Evidence: 0.64
Remarkable(beta blocker, be contraindicated in vasospastic angina) ⋁
Evidence: 0.70
¬ Plausible(beta blocker, be contraindicated in vasospastic angina)
0.35
Rule weight: 0.60
Evidence weight: 0.77
Similarity weight: 0.76
Evidence: 0.10
Plausible(agent, be added to aspirin) ⋁
Evidence: 0.67
Remarkable(beta blocker, be contraindicated in patients with asthma) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in patients with asthma)

Salient implies Plausible

0.26
Rule weight: 0.28
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.10
Plausible(agent, be added to aspirin) ⋁
Evidence: 0.10
¬ Salient(agent, be added to aspirin)

Similarity expansion

0.54
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.76
Evidence: 0.07
Remarkable(agent, be added to aspirin) ⋁
Evidence: 0.17
¬ Remarkable(agent, be added to medicines)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.76
Evidence: 0.10
Salient(agent, be added to aspirin) ⋁
Evidence: 0.21
¬ Salient(agent, be added to medicines)
0.49
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.76
Evidence: 0.10
Plausible(agent, be added to aspirin) ⋁
Evidence: 0.27
¬ Plausible(agent, be added to medicines)
0.44
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.76
Evidence: 0.38
Typical(agent, be added to aspirin) ⋁
Evidence: 0.53
¬ Typical(agent, be added to medicines)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.10
Salient(agent, be added to aspirin) ⋁
Evidence: 0.38
¬ Typical(agent, be added to aspirin) ⋁
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin)

Typical implies Plausible

0.31
Rule weight: 0.48
Evidence weight: 0.66
Similarity weight: 1.00
Evidence: 0.10
Plausible(agent, be added to aspirin) ⋁
Evidence: 0.38
¬ Typical(agent, be added to aspirin)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.96
Similarity weight: 0.79
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin) ⋁
Evidence: 0.50
¬ Typical(beta blocker, be effective as antianginal medications)
0.10
Rule weight: 0.14
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in angina)
0.10
Rule weight: 0.14
Evidence weight: 0.97
Similarity weight: 0.75
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin) ⋁
Evidence: 0.36
¬ Typical(beta blocker, be used in hypertension)
0.10
Rule weight: 0.14
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin) ⋁
Evidence: 0.74
¬ Typical(beta blocker, be contraindicated in vasospastic angina)
0.10
Rule weight: 0.14
Evidence weight: 0.94
Similarity weight: 0.76
Evidence: 0.07
¬ Remarkable(agent, be added to aspirin) ⋁
Evidence: 0.82
¬ Typical(beta blocker, be contraindicated in patients with asthma)